One Gustave L. Levy Place, Box 1272, New York, NYTHE DEANE CENTER Mount Sinai School of Medicine Finding Relief for BPH Continued from page 1

First Page		Document Content
Date: 2010-03-03 19:17:24 Bacterial diseases Sexually transmitted diseases and infections Prostate cancer Benign prostatic hyperplasia Prostate Chronic prostatitis/chronic pelvic pain syndrome Simon J. Hall Prostatitis Transurethral resection of the prostate Medicine Health Cancer screening		One Gustave L. Levy Place, Box 1272, New York, NYTHE DEANE CENTER Mount Sinai School of Medicine Finding Relief for BPH Continued from page 1 Add to Reading List Source URL: icahn.mssm.edu Download Document from Source Website File Size: 334,36 KB Share Document on Facebook

$6-Day Intensive Treatment Protocol for Refractory Chronic Prostatitis/Chronic Pelvic Pain Syndrome Using Myofascial Release and Paradoxical Relaxation Training$	6-Day Intensive Treatment Protocol for Refractory Chronic Prostatitis/Chronic Pelvic Pain Syndrome Using Myofascial Release and Paradoxical Relaxation Training DocID: 1d69x - View Document
	http://www.reuters.com/articlePrint?articleId=US180628%2B24-Jun DocID: 19NC0 - View Document
	TARIS® Secures $12.5 Million in Additional Financing; Initiates Phase 2 Trial of Lead Product Candidate Lexington, MA – April 2nd, 2013 – TARIS Biomedical®, a specialty pharmaceutical company developing innovative, DocID: 19L9P - View Document
	TARIS SUCCESSFULLY COMPLETES PHASE 1 STUDY -- First Human Trial Enables Development for Several Indications -Lexington, MA – December 2, 2009 – TARIS Biomedical, a specialty pharmaceutical company pioneering the fiel DocID: 19F0k - View Document
	TARIS® Announces Dosing of First Patient in Second Phase 2 Clinical Study of LiRIS® in Interstitial Cystitis Lexington, MA – April 2nd, 2013 – TARIS Biomedical®, a specialty pharmaceutical company developing innov DocID: 19AVH - View Document